Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in is favor in a patent dispute with Medtronic ...

TNDM Tandem Diabetes Care, Inc.